Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases

Lipoprotein lipase (LPL) is a glycoprotein that is produced and secreted into the interstitial space in various tissues, including the cardiac muscle, adipose tissue, macrophages, and skeletal muscle. LPL activity could be affected by genetic alterations which result in changes in lipid metabolism....

Full description

Bibliographic Details
Main Authors: Rafaqat Sana, Rafaqat Saira, Sharif Saima, Klisić Aleksandra
Format: Article
Language:srp
Published: Pharmaceutical Association of Serbia, Belgrade, Serbia 2024-01-01
Series:Arhiv za farmaciju
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2024/0004-19632401038R.pdf
_version_ 1827293621475344384
author Rafaqat Sana
Rafaqat Saira
Sharif Saima
Klisić Aleksandra
author_facet Rafaqat Sana
Rafaqat Saira
Sharif Saima
Klisić Aleksandra
author_sort Rafaqat Sana
collection DOAJ
description Lipoprotein lipase (LPL) is a glycoprotein that is produced and secreted into the interstitial space in various tissues, including the cardiac muscle, adipose tissue, macrophages, and skeletal muscle. LPL activity could be affected by genetic alterations which result in changes in lipid metabolism. This review article only focuses on reporting the recent studies which mainly explain the role of the LPL gene variants in metabolic syndrome and cardiovascular diseases. There are over 100 LPL gene variants, but this review article reported rs1801177, rs118204069, rs118204057, rs118204060, rs118204068, rs268, and rs328 as the most common in metabolic syndrome patients. In cardiovascular diseases, LPL variants rs1801177, rs268 and rs328 were the most prevalent. Therefore, it is suggested that further studies should be conducted to identify the LPL gene variants in other cardiovascular diseases, including cardiac arrhythmia. This review article concludes that LPL deficiency and dysfunction are associated with many diseases, such as obesity, insulin resistance, diabetes, chylomicronemia, atherosclerosis, myocardial infarction, coronary artery disease, and stroke.
first_indexed 2024-04-24T13:42:14Z
format Article
id doaj.art-dcfea8128fd44e1d976ea977c14a6e62
institution Directory Open Access Journal
issn 0004-1963
2217-8767
language srp
last_indexed 2024-04-24T13:42:14Z
publishDate 2024-01-01
publisher Pharmaceutical Association of Serbia, Belgrade, Serbia
record_format Article
series Arhiv za farmaciju
spelling doaj.art-dcfea8128fd44e1d976ea977c14a6e622024-04-04T08:11:07ZsrpPharmaceutical Association of Serbia, Belgrade, SerbiaArhiv za farmaciju0004-19632217-87672024-01-01741385510.5937/arhfarm74-480700004-19632401038RRole of lipoprotein lipase variants in metabolic disorders and cardiovascular diseasesRafaqat Sana0Rafaqat Saira1Sharif Saima2Klisić Aleksandra3https://orcid.org/0000-0001-7870-0996Lahore College for Women University, Department of Biotechnology (Human Genetics), Lahore, Punjab, PakistanLahore College for Women University, Department of Zoology (Molecular Physiology), Lahore, Punjab, PakistanLahore College for Women University, Department of Zoology (Molecular Physiology), Lahore, Punjab, PakistanUniversity of Montenegro, Faculty of Medicine, Podgorica, MontenegroLipoprotein lipase (LPL) is a glycoprotein that is produced and secreted into the interstitial space in various tissues, including the cardiac muscle, adipose tissue, macrophages, and skeletal muscle. LPL activity could be affected by genetic alterations which result in changes in lipid metabolism. This review article only focuses on reporting the recent studies which mainly explain the role of the LPL gene variants in metabolic syndrome and cardiovascular diseases. There are over 100 LPL gene variants, but this review article reported rs1801177, rs118204069, rs118204057, rs118204060, rs118204068, rs268, and rs328 as the most common in metabolic syndrome patients. In cardiovascular diseases, LPL variants rs1801177, rs268 and rs328 were the most prevalent. Therefore, it is suggested that further studies should be conducted to identify the LPL gene variants in other cardiovascular diseases, including cardiac arrhythmia. This review article concludes that LPL deficiency and dysfunction are associated with many diseases, such as obesity, insulin resistance, diabetes, chylomicronemia, atherosclerosis, myocardial infarction, coronary artery disease, and stroke.https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2024/0004-19632401038R.pdflipoprotein lipasemetabolic syndromecardiovascular diseasespathophysiologymutation
spellingShingle Rafaqat Sana
Rafaqat Saira
Sharif Saima
Klisić Aleksandra
Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
Arhiv za farmaciju
lipoprotein lipase
metabolic syndrome
cardiovascular diseases
pathophysiology
mutation
title Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
title_full Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
title_fullStr Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
title_full_unstemmed Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
title_short Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
title_sort role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
topic lipoprotein lipase
metabolic syndrome
cardiovascular diseases
pathophysiology
mutation
url https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2024/0004-19632401038R.pdf
work_keys_str_mv AT rafaqatsana roleoflipoproteinlipasevariantsinmetabolicdisordersandcardiovasculardiseases
AT rafaqatsaira roleoflipoproteinlipasevariantsinmetabolicdisordersandcardiovasculardiseases
AT sharifsaima roleoflipoproteinlipasevariantsinmetabolicdisordersandcardiovasculardiseases
AT klisicaleksandra roleoflipoproteinlipasevariantsinmetabolicdisordersandcardiovasculardiseases